摘要
本文系统分析我国医药化学品的现状,并利用区域显示比较优势指数(RRCA)评价了我国医药化学品出口的竞争优势。实证分析显示,尽管中国某些医药化学品在美国市场上拥有较强的竞争力,但整体来讲,中国医药化学品在美国市场的竞争力很低,且仍处于下降的趋势。据此,本文提出了提高中国医药化学品在美国市场竞争力的对策方案。
The status of pharmaceutical chemicals in China was analyzed and the competitive advantage of the export of China's pharmaceutical chemicals was evaluated by using RRCA index. The empirical results show that despite China has strong competitive advantages in some pharmaceutical chemicals, but overall speaking, their competitiveness is low and still in declining trend in American market. Accordingly, some measures for raising their competitiveness are proposed in this paper.
出处
《上海医药》
CAS
2014年第1期47-49,共3页
Shanghai Medical & Pharmaceutical Journal